NCT03765697View on ClinicalTrials.gov

A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia

PHASE3CompletedINTERVENTIONAL
Enrollment

259

Participants

Timeline

Start Date

July 16, 2003

Primary Completion Date

July 12, 2005

Study Completion Date

February 12, 2009

Conditions
Post Herpetic Neuralgia
Interventions
DRUG

Lidocaine 5% medicated plaster

Topical application at the site of skin affected by painful PHN for up to 12 hours per day (plaster-free interval at least 12 hours).

Sponsors

Lead Sponsor

Grünenthal GmbH
All Listed Sponsors
lead

Grünenthal GmbH

INDUSTRY